نتائج البحث - "glucagon like peptide‐1 receptor agonists"

1

دورية أكاديمية

Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy

المؤلفون: Cesta, Carolyn E., Rotem, Ran, Bateman, Brian T., Chodick, Gabriel, Cohen, Jacqueline M., Furu, Kari, Gissler, Mika, Huybrechts, Krista F., Kjerpeseth, Lars J., Leinonen, Maarit K., Pazzagli, Laura, Zoega, Helga, Seely, Ellen W., Patorno, Elisabetta, Hernández-Díaz, Sonia

المساهمون: Faculty of Medicine

مصطلحات موضوعية: Cohort Studies, Diabetes Mellitus, Type 2/drug therapy, Dipeptidyl-Peptidase IV Inhibitors/therapeutic use, Female, Glucagon-Like Peptide-1 Receptor Agonists, Glucagon-Like Peptide-1 Receptor/agonists, Humans, Hypoglycemic Agents/adverse effects, Insulin/adverse effects, Pregnancy, Sodium-Glucose Transporter 2 Inhibitors/adverse effects, Sulfonylurea Compounds/adverse effects, Internal Medicine

وصف الملف: 144-152

العلاقة: JAMA Internal Medicine; 184(2); http://www.scopus.com/inward/record.url?scp=85181034956&partnerID=8YFLogxKTest; Cesta , C E , Rotem , R , Bateman , B T , Chodick , G , Cohen , J M , Furu , K , Gissler , M , Huybrechts , K F , Kjerpeseth , L J , Leinonen , M K , Pazzagli , L , Zoega , H , Seely , E W , Patorno , E & Hernández-Díaz , S 2024 , ' Safety of GLP-1 Receptor Agonists and Other Second-Line Antidiabetics in Early Pregnancy ' , JAMA Internal Medicine , vol. 184 , no. 2 , pp. 144-152 . https://doi.org/10.1001/jamainternmed.2023.6663Test; 215155202; 198ef4fd-ee4e-4302-b551-12e929142bad; 85181034956; https://hdl.handle.net/20.500.11815/4806Test

الإتاحة: https://doi.org/20.500.11815/4806Test
https://doi.org/10.1001/jamainternmed.2023.6663Test
https://hdl.handle.net/20.500.11815/4806Test

View record in BASE

2

دورية أكاديمية

Fibroblast growth factor-21 is required for weight loss induced by the glucagon-like peptide-1 receptor agonist liraglutide in male mice fed high carbohydrate diets

المؤلفون: Thao D.V. Le, Payam Fathi, Amanda B. Watters, Blair J. Ellis, Gai-Linn K. Besing, Nadejda Bozadjieva-Kramer, Misty B. Perez, Andrew I. Sullivan, Jesse P. Rose, Laurie L. Baggio, Jacqueline Koehler, Jennifer L. Brown, Michelle B. Bales, Kaitlyn G. Nwaba, Jonathan E. Campbell, Daniel J. Drucker, Matthew J. Potthoff, Randy J. Seeley, Julio E. Ayala

المصدر: Molecular Metabolism, Vol 72, Iss , Pp 101718- (2023)

مصطلحات موضوعية: Glucagon-like peptide-1 receptor agonists, Fibroblast growth factor-21, Liraglutide, Carbohydrate, Food intake, Weight loss, Internal medicine, RC31-1245

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S2212877823000522Test; https://doaj.org/toc/2212-8778Test

الوصول الحر: https://doaj.org/article/d72c33cca2fa47dca8da218c427827beTest

View record in DOAJ

النص الكامل

3

دورية أكاديمية

Cardiovascular risk and lifetime benefit from preventive treatment in type 2 diabetes: A post hoc analysis of the CAPTURE study

المؤلفون: the CAPTURE investigators

المساهمون: Interne Geneeskunde Vasculaire, Circulatory Health, MS Interne Geneeskunde

وصف الملف: application/pdf

العلاقة: https://dspace.library.uu.nl/handle/1874/448515Test

الإتاحة: https://dspace.library.uu.nl/handle/1874/448515Test

View record in BASE

4

دورية أكاديمية

Time and metabolic state-dependent effects of GLP-1R agonists on NPY/AgRP and POMC neuronal activity in vivo

المؤلفون: Yanbin Dong, Jamie Carty, Nitsan Goldstein, Zhenyan He, Eunsang Hwang, Dominic Chau, Briana Wallace, Anita Kabahizi, Linh Lieu, Yunqian Peng, Yong Gao, Ling Hu, J. Nicholas Betley, Kevin W. Williams

المصدر: Molecular Metabolism, Vol 54, Iss , Pp 101352- (2021)

مصطلحات موضوعية: Liraglutide and semaglutide, Long-acting glucagon-like peptide-1 receptor agonists (GLP-1RAs), TRPC5 subunit, Metabolic state-dependent effects, GLP-1R Agonists on NPY/AgRP neuron, POMC Neuronal activity, Internal medicine, RC31-1245

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S221287782100199XTest; https://doaj.org/toc/2212-8778Test

الوصول الحر: https://doaj.org/article/4ec2aa488f164583b0cbb499e20a9df9Test

View record in DOAJ

النص الكامل

5

دورية أكاديمية

GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art

المؤلفون: Michael A. Nauck, Daniel R. Quast, Jakob Wefers, Juris J. Meier

المصدر: Molecular Metabolism, Vol 46, Iss , Pp 101102- (2021)

مصطلحات موضوعية: Glucagon-like peptide-1 receptor agonists, Exenatide, Lixisenatide, Liraglutide, Dulaglutide, Albiglutide, Internal medicine, RC31-1245

وصف الملف: electronic resource

العلاقة: http://www.sciencedirect.com/science/article/pii/S2212877820301769Test; https://doaj.org/toc/2212-8778Test

الوصول الحر: https://doaj.org/article/6a8b1c7fd03844fc9ad3a6585f22a6eaTest

View record in DOAJ

النص الكامل

6

Changes in the use of glucose‐lowering drugs: A Danish nationwide study

المؤلفون: Jacob Andersen, Anton Pottegård, Reimar Thomsen, Jens Sondergaard, Tina VilsbÃ¸ll

المصدر: Pottegård, A, Andersen, J H, Søndergaard, J, Thomsen, R W & Vilsbøll, T 2023, ' Changes in the use of glucose-lowering drugs : A Danish nationwide study ', Diabetes, Obesity and Metabolism, vol. 25, no. 4, pp. 1002-1010 . https://doi.org/10.1111/dom.14947Test

مصطلحات موضوعية: glucagon-like peptide-1 receptor agonists, sodium-glucose co-transporter-2 inhibitors, pharmacoepidemiology, Endocrinology, antidiabetics, Endocrinology, Diabetes and Metabolism, Internal Medicine, glucose-lowering medication, type 2 diabetes, drug utilization

وصف الملف: application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d302e561a55856ce8a81559d7088166Test
https://doi.org/10.1111/dom.14947Test

7

Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes

المؤلفون: Max Nieuwdorp, Richard G. IJzerman, Hiddo J.L. Heerspink, Annemarie B van der Aart-van der Beek, Daniël H. van Raalte, Klaas Hoogenberg, Charlotte C. van Ruiten

المساهمون: Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Groningen Kidney Center (GKC), Experimental Vascular Medicine, Vascular Medicine, ACS - Diabetes & metabolism, AGEM - Amsterdam Gastroenterology Endocrinology Metabolism, Internal medicine, Amsterdam Gastroenterology Endocrinology Metabolism, AGEM - Endocrinology, metabolism and nutrition

المصدر: Diabetes, Obesity and Metabolism, 23(8), 1851-1858. Wiley
Diabetes, obesity & metabolism, 23(8), 1851-1858. Wiley-Blackwell
Diabetes, Obesity and Metabolism, 23(8), 1851-1858. Wiley-Blackwell
van Ruiten, C C, van der Aart-van der Beek, A B, IJzerman, R G, Nieuwdorp, M, Hoogenberg, K, van Raalte, D H & Heerspink, H J L 2021, ' Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial ', Diabetes, Obesity and Metabolism, vol. 23, no. 8, pp. 1851-1858 . https://doi.org/10.1111/dom.14410Test
Diabetes, Obesity & Metabolism

مصطلحات موضوعية: medicine.medical_specialty, Endocrinology, Diabetes and Metabolism, exenatide, Urology, Renal function, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, Kidney, Placebo, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Endocrinology, Double-Blind Method, Glucosides, Internal Medicine, medicine, Humans, glucagon‐like peptide‐1 receptor agonists, Obesity, Benzhydryl Compounds, Dapagliflozin, glucagon-like peptide-1 receptor agonists, Creatinine, business.industry, Original Articles, GLP‐1RA, dapagliflozin, medicine.disease, GLP-1RA, Confidence interval, diabetic kidney disease, Clinical trial, Diabetes Mellitus, Type 2, chemistry, Original Article, business, Exenatide, SGLT2 inhibitors, medicine.drug